Citation Impact
Citing Papers
Tandem Duplication Producing a Novel Oncogenic BRAF Fusion Gene Defines the Majority of Pilocytic Astrocytomas
2008
Distinct Genetic Signatures among Pilocytic Astrocytomas Relate to Their Brain Region Origin
2007
Tumor-Associated Macrophages Promote Angiogenesis and Melanoma Growth via Adrenomedullin in a Paracrine and Autocrine Manner
2011
Recurrent BRAF mutations in Langerhans cell histiocytosis
2010 Standout
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
2009 Standout
Partial Response and Nonresponse to Antidepressant Therapy
2002
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and Continuation Treatment of Major Depressive Disorder
2002
Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report
2006 Standout
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care
2007
Sertraline versus imipramine to prevent relapse in chronic depression
2001
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy.
2000 Standout
Interleukin-1 Regulates the Expression of Sphingosine Kinase 1 in Glioblastoma Cells
2008
Genome-scale DNA methylation maps of pluripotent and differentiated cells
2008 StandoutNature
Acromegaly
2006 Standout
Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice
2006 StandoutNobel
Continuation and maintenance therapy with antidepressive agents
1991
MANAGEMENT OF ENDOCRINE DISEASE: The burden of Cushing's disease: clinical and health-related quality of life aspects
2012
IDH1andIDH2Mutations in Gliomas
2009 Standout
Complementarity between targeted real-time specific PCR and conventional broad-range 16S rDNA PCR in the syndrome-driven diagnosis of infectious diseases
2014
DESIGN AND REPORTING MODIFICATIONS IN INDUSTRY-SPONSORED COMPARATIVE PSYCHOPHARMACOLOGY TRIALS
2002
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials
2001 Standout
Why Olanzapine Beats Risperidone, Risperidone Beats Quetiapine, and Quetiapine Beats Olanzapine: An Exploratory Analysis of Head-to-Head Comparison Studies of Second-Generation Antipsychotics
2006
Contribution of platelets to tumour metastasis
2011 Standout
Human Genetics Shape the Gut Microbiome
2014 Standout
Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
1998 Standout
Stereotactic radiosurgery for Cushing disease: a review
2007
Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours
2009
Pituicytoma: Report of Two Cases and Clues Regarding Histogenesis
2004
Receptor and secreted targets of Wnt-1/β-catenin signalling in mouse mammary epithelial cells
2005
Spindle cell oncocytoma of the adenohypophysis: Report of a case with a 16-year follow-up
2006
Maintenance Phase Efficacy of Sertraline for Chronic Depression<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
1998
Status of minor depression or dysthymia in primary care following a randomized controlled treatment
2001
Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates ‘neuroendocrine phenotype’ in LNCaP prostate tumor cells
2007
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Cushing's syndrome
2015 Standout
Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice
2006 Standout
Molecular defects in the pathogenesis of pituitary tumours
2003
Preoperative thrombocytosis predicts poor survival in patients with glioblastoma
2007
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
2009 StandoutNobel
Medical Treatment of Cushing's Disease
2013
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
2012
Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: Involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors
2004
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
Newer atypical antipsychotic medication in comparison to clozapine: a systematic review of randomized trials
2002
The monolayer formation of Bergmann glial cells is regulated by Notch/RBP-J signaling
2007 StandoutNobel
Selective Serotonin Reuptake Inhibitors: Pharmacologic Profiles and Potential Therapeutic Distinctions
1994
Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus
2005 Standout
Linking “big” personality traits to anxiety, depressive, and substance use disorders: A meta-analysis.
2010 Standout
Molecular mechanisms of the antiproliferative activity of somatostatin receptors (SSTRs) in neuroendocrine tumors
2007
Epidemiology of Acromegaly
1999
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Clinical potential of minocycline for neurodegenerative disorders
2004
Effectiveness of Second-Generation Antipsychotics in Patients With Treatment-Resistant Schizophrenia: A Review and Meta-Analysis of Randomized Trials
2001
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
2021 StandoutNobel
The Impact of the Gut Microbiota on Human Health: An Integrative View
2012 Standout
Ongoing Revolution in Bacteriology: Routine Identification of Bacteria by Matrix‐Assisted Laser Desorption Ionization Time‐of‐Flight Mass Spectrometry
2009 Standout
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
2013 Standout
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
Imprinting of the Gsα gene GNAS1 in the pathogenesis of acromegaly
2001
The new and evolving pharmacotherapy of schizophrenia
2003
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
AGA technical review on irritable bowel syndrome
2002 Standout
An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia
2004
From inflammation to sickness and depression: when the immune system subjugates the brain
2007 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
The PHQ-9
2001 Standout
Receptor Activity-modifying Proteins 2 and 3 Have Distinct Physiological Functions from Embryogenesis to Old Age
2007 StandoutNobel
Three-Year Outcomes for Maintenance Therapies in Recurrent Depression
1990
Fluoxetine: A spectrum of clinical applications and postulates of underlying mechanisms
1993
A Meta-analysis of the Efficacy of Second-Generation Antipsychotics
2003
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
DNA methylation and human disease
2005 Standout
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
2012 StandoutNobel
The human microbiome: at the interface of health and disease
2012 Standout
Adrenomedullin: a new target for the design of small molecule modulators with promising pharmacological activities
2005
Transgenic approaches to cognition
1995 StandoutNobel
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Spindle Cell Oncocytoma of the Adenohypophysis
2005
Risperidone versus typical antipsychotic medication for schizophrenia
2003
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
The Current State of Peptide Drug Discovery: Back to the Future?
2017
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Hydrops Fetalis, Cardiovascular Defects, and Embryonic Lethality in Mice Lacking the Calcitonin Receptor-Like Receptor Gene
2006 StandoutNobel
A controlled comparison of sertraline and fluoxetine in acute and continuation treatment of major depression
1995
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials
2001 Standout
Transsphenoidal surgery for Cushing's disease: a review of success rates, remission predictors, management of failed surgery, and Nelson's Syndrome
2007
Metagenomics of the Human Body
2010
Putting trials on trial--the costs and consequences of small trials in depression: a systematic review of methodology.
1997
Familial Isolated Pituitary Adenomas (FIPA) and the Pituitary Adenoma Predisposition due to Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene
2013
Gamma Knife surgery for Cushing's disease
2007
Astrocyte-Specific Inactivation of the Neurofibromatosis 1 Gene (NF1) Is Insufficient for Astrocytoma Formation
2002
The 2007 WHO Classification of Tumours of the Central Nervous System
2010 Standout
Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study
2007
Transduction of psychosocial stress into the neurobiology of recurrent affective disorder
1992 Standout
Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-Analyses
2001 Standout
Works of H. Dufour being referenced
Treatment-resistant schizophrenia: clinical experience with new antipsychotics
1996
Neutralization of Adrenomedullin Inhibits the Growth of Human Glioblastoma Cell Lines in Vitro and Suppresses Tumor Xenograft Growth in Vivo
2002
Gamma knife radiosurgery is a successful adjunctive treatment in Cushing’s disease
2007
Dimensional assessment of onset of action of antidepressants: a comparative study of moclobemide vs. clomipramine in depressed patients with blunted affect and psychomotor retardation
1998
Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapy
2005
Risperidone Versus Clozapine in Treatment-Resistant Chronic Schizophrenia: A Randomized Double-Blind Study
1998
Pituicytomas, a mis-diagnosed benign tumor of the neurohypophysis: report of three cases
2002
PAI-1 and EGFR expression in adult glioma tumors: toward a molecular prognostic classification
2002
Minocycline and benign intracranial hypertension
1992
Pronostic and Therapeutic Consequences of Gsα Mutations in Somatotroph Adenomas1
1998
The Expansion of the Microbiological Spectrum of Brain Abscesses with Use of Multiple 16S Ribosomal DNA Sequencing
2009
Are Juvenile Pilocytic Astrocytomas Benign Tumors? A Cytogenetic Study in 24 Cases
1998
P-4-73 A randomized double-bind trial of risperidone versus clozapine for treatment-resistant chronic schizophrenia
1995
The Prophylactic Efficacy of Fluoxetine in Unipolar Depression
1988
Gsα overexpression and loss of Gsα imprinting in human somatotroph adenomas: Association with tumor size and response to pharmacologic treatment
2007
Citalopram‐lithium combination treatment of elderly depressed patients: A pilot study
1995
BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotide.
2005